Living with Neuroendocrine TumorsPeople with neuroendocrine tumors can lead meaningful, active, productive lives. Learn how you can make the most of every day. Managing NET symptoms Eating right Being active, staying safe Managing emotions Finding support See how others live with NETs made one or more lifestyle changes due to NETs2 0 % report general fatigue/muscle weakness2 0 % experienced diarrhea2 0 % The latest in NETRF News A New Treatment Option for NET Patients The U.S. Food and Drug Administration (FDA) has approved cabozantinib for the treatment of previously Early Positive Signs in CAR T Cell Therapy Trial Chimeric Therapeutics is reporting early signs of efficacy in the world’s first clinical trial of NETRF Grantees Recognized for their Expertise at ENETS Neuroendocrine cancer researchers from around the world gathered in Krakow, Poland for the 22nd Annual Browse our Youtube Channel Video Library Subscribe to NETRF Podcast Attend a NET patient conference Patient Events Find support groups in your area Check out patient advocacy groups 2Singh S, Granberg D, Wolin E, et al. Patient-reported burden of a neuroendocrine tumor (NET) diagnosis: results from the first global survey of patients with NETs. J Glob Oncol. 2016;2(1):43-53.
A New Treatment Option for NET Patients The U.S. Food and Drug Administration (FDA) has approved cabozantinib for the treatment of previously
Early Positive Signs in CAR T Cell Therapy Trial Chimeric Therapeutics is reporting early signs of efficacy in the world’s first clinical trial of
NETRF Grantees Recognized for their Expertise at ENETS Neuroendocrine cancer researchers from around the world gathered in Krakow, Poland for the 22nd Annual